Items Tagged ‘Merkel cell carcinoma’

June 14th, 2016

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma

By

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy could represent a new treatment option for these hard to treat cancers. Merkel cell carcinoma is a rare aggressive skin cancer with limited treatment options for […]

View full entry

Tags: General Skin Cancer, keytruda, Merkel cell carcinoma, News, pembrolizumab, Skin Cancer